Does ARTV or EMBC pay a bigger dividend?

EMBC pays a dividend (5.44% yield), while ARTV has no payments in the available dividend history.

Is ARTV or EMBC more profitable?

EMBC runs the higher net margin — ARTV at 0.00% versus EMBC at 8.59%.

Artiva Biotherapeutics, Inc. (ARTV) vs Embecta Corp. (EMBC)

A side-by-side comparison of Artiva Biotherapeutics, Inc. and Embecta Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARTV

Artiva Biotherapeutics, Inc.

$341M

$6.99HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

EMBC

Embecta Corp.

$354M

$5.98HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ARTV vs EMBC

growth of $100 · dividends reinvested · last 2y

ARTV -40.6% (-22.9%/yr)EMBC -51.4% (-30.3%/yr)ARTV compounded faster over this window

ARTV EMBC

ARTV vs EMBC: by the numbers

•EMBC is the larger company ($354M vs $341M market cap).
•EMBC is profitable (8.59% net margin) while ARTV runs a net loss (0.00%).
•EMBC pays a dividend (5.44% yield), while ARTV has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ARTV	EMBC
P/E ratio	N/A	4.04
Forward P/E	N/A	3.39
P/S ratio	N/A	0.35
P/B ratio	0.98	N/A
EV / EBITDA	N/A	5.38
FCF yield	N/A	46.43%

Profitability

Metric	ARTV	EMBC
Gross margin	0.00%	59.89%
Operating margin	0.00%	24.85%
Net margin	0.00%	8.59%
ROE	-26.14%	N/A
ROIC	-27.16%	17.99%

Dividends

Metric	ARTV	EMBC
Dividend yield	N/A	5.44%
Payout ratio	N/A	21.62%

Growth (annualized)

Metric	ARTV	EMBC
Revenue CAGR (5Y)	N/A	-0.09%
EPS CAGR (5Y)	N/A	-26.22%
FCF CAGR (5Y)	N/A	-16.77%

Frequently asked

Does ARTV or EMBC pay a bigger dividend?: EMBC pays a dividend (5.44% yield), while ARTV has no payments in the available dividend history.
Is ARTV or EMBC more profitable?: EMBC runs the higher net margin — ARTV at 0.00% versus EMBC at 8.59%.

Go deeper

Full ARTV analysis Full EMBC analysis Interactive comparison tool

Dig into the metrics

Embecta P/E ratio Embecta dividend yield Artiva Biotherapeutics ROE Embecta ROE Artiva Biotherapeutics operating margin Embecta operating margin Artiva Biotherapeutics revenue growth Embecta revenue growth Artiva Biotherapeutics free cash flow Embecta free cash flow

Artiva Biotherapeutics & Embecta appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.